Detailed information for compound 430522

Basic information

Technical information
  • TDR Targets ID: 430522
  • Name: 4-(4-methylphenyl)-2-(3-pyridin-2-yl-5-thioph en-2-yl-3,4-dihydropyrazol-2-yl)-1,3-thiazole
  • MW: 402.535 | Formula: C22H18N4S2
  • H donors: 0 H acceptors: 2 LogP: 5.39 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)c1csc(n1)N1N=C(CC1c1ccccn1)c1cccs1
  • InChi: 1S/C22H18N4S2/c1-15-7-9-16(10-8-15)19-14-28-22(24-19)26-20(17-5-2-3-11-23-17)13-18(25-26)21-6-4-12-27-21/h2-12,14,20H,13H2,1H3
  • InChiKey: JKGIVAZVPYQJOQ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-(p-tolyl)-2-[3-(2-pyridyl)-5-(2-thienyl)-3,4-dihydropyrazol-2-yl]thiazole
  • 4-(p-tolyl)-2-[5-(2-pyridyl)-3-(2-thienyl)-2-pyrazolin-1-yl]thiazole
  • 2-[2-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-5-thiophen-2-yl-3,4-dihydropyrazol-3-yl]pyridine
  • 2-[2-[4-(4-methylphenyl)thiazol-2-yl]-5-(2-thienyl)-3,4-dihydropyrazol-3-yl]pyridine
  • 2-[2-[4-(4-methylphenyl)-2-thiazolyl]-5-(2-thienyl)-3,4-dihydropyrazol-3-yl]pyridine

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus fatty acid amide hydrolase 1 0.2104 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0773 0.3129 1
Trypanosoma brucei lipase domain protein, putative 0.0773 0.3129 1
Trichomonas vaginalis lipase containing protein, putative 0.0773 0.3129 0.5
Mycobacterium tuberculosis Probable amidase AmiB2 (aminohydrolase) 0.0254 0.0447 1
Mycobacterium tuberculosis Possible amidase (aminohydrolase) 0.0254 0.0447 1
Mycobacterium ulcerans amidase 0.0254 0.0447 1
Mycobacterium ulcerans peptide amidase, GatA 0.0254 0.0447 1
Echinococcus granulosus fatty acid amide hydrolase 1 0.2104 1 1
Leishmania major hypothetical protein, conserved 0.0773 0.3129 1
Chlamydia trachomatis glutamyl-tRNA(Gln) amidotransferase subunit A 0.0254 0.0447 0.5
Wolbachia endosymbiont of Brugia malayi aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0254 0.0447 0.5
Mycobacterium tuberculosis Probable amidase AmiD (acylamidase) (acylase) 0.0254 0.0447 1
Mycobacterium ulcerans amidase 0.0254 0.0447 1
Loa Loa (eye worm) lipase 0.0773 0.3129 0.2808
Echinococcus granulosus sn1 specific diacylglycerol lipase beta 0.0773 0.3129 0.2808
Mycobacterium leprae PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) 0.0254 0.0447 0.5
Mycobacterium ulcerans amidase 0.0254 0.0447 1
Trichomonas vaginalis lipase containing protein, putative 0.0773 0.3129 0.5
Plasmodium vivax glutamyl-tRNA(Gln) amidotransferase subunit A, putative 0.0254 0.0447 0.5
Echinococcus multilocularis sn1 specific diacylglycerol lipase beta 0.0773 0.3129 0.2808
Mycobacterium ulcerans aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0254 0.0447 1
Trypanosoma cruzi hypothetical protein, conserved 0.0773 0.3129 1
Plasmodium falciparum glutamyl-tRNA(Gln) amidotransferase subunit A 0.0254 0.0447 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.2104 1 1
Loa Loa (eye worm) hypothetical protein 0.2104 1 1
Brugia malayi Lipase family protein 0.0773 0.3129 0.2808
Mycobacterium tuberculosis Probable amidase AmiA2 (aminohydrolase) 0.0254 0.0447 1
Mycobacterium tuberculosis Probable amidase AmiC (aminohydrolase) 0.0254 0.0447 1
Treponema pallidum aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0254 0.0447 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.2104 1 1
Schistosoma mansoni amidase 0.2104 1 1
Mycobacterium ulcerans amidase 0.0254 0.0447 1
Onchocerca volvulus 0.0773 0.3129 0.5
Mycobacterium leprae PROBABLE AMIDASE AMIC (AMINOHYDROLASE) 0.0254 0.0447 0.5
Schistosoma mansoni fatty-acid amide hydrolase 0.2104 1 1
Trypanosoma brucei lipase domain protein, putative 0.0773 0.3129 1
Mycobacterium ulcerans amidase 0.0254 0.0447 1

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 62.5 ug ml-1 Antibacterial activity against Aeromonas hydrophila by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 62.5 ug ml-1 Antifungal activity against Candida albicans by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 62.5 ug ml-1 Antifungal activity against Candida glabrata by broth dilution antifungal susceptibility testing ChEMBL. 17125888
MIC (functional) = 62.5 ug ml-1 Antifungal activity against Candida albicans by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 125 ug ml-1 Antibacterial activity against Escherichia coli NRRL B3704 by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 125 ug ml-1 Antibacterial activity against Salmonella typhimurium NRRL B4420 by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 125 ug ml-1 Antibacterial activity against Escherichia coli NRRL B3704 by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 250 ug ml-1 Antibacterial activity against Staphylococcus aureus NRRL B767 by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 250 ug ml-1 Antibacterial activity against Bacillus cereus NRRL B3711 by microbroth dilution method ChEMBL. 17125888
MIC (functional) = 250 ug ml-1 Antibacterial activity against Streptococcus faecalis NRRL B14617 by microbroth dilution method ChEMBL. 17125888

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.